Core Outcome Set for IgE-mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study 'COMFA'
- PMID: 38433402
- DOI: 10.1111/all.16023
Core Outcome Set for IgE-mediated food allergy clinical trials and observational studies of interventions: International Delphi consensus study 'COMFA'
Abstract
Background: IgE-mediated food allergy (FA) is a global health concern with substantial individual and societal implications. While diverse intervention strategies have been researched, inconsistencies in reported outcomes limit evaluations of FA treatments. To streamline evaluations and promote consistent reporting, the Core Outcome Measures for Food Allergy (COMFA) initiative aimed to establish a Core Outcome Set (COS) for FA clinical trials and observational studies of interventions.
Methods: The project involved a review of published clinical trials, trial protocols and qualitative literature. Outcomes found as a result of review were categorized and classified, informing a two-round online-modified Delphi process followed by hybrid consensus meeting to finalize the COS.
Results: The literature review, taxonomy mapping and iterative discussions with diverse COMFA group yielded an initial list of 39 outcomes. The iterative online and in-person meetings reduced the list to 13 outcomes for voting in the formal Delphi process. One more outcome was added based on participant suggestions after the first Delphi round. A total of 778 participants from 52 countries participated, with 442 participating in both Delphi rounds. No outcome met a priori criteria for inclusion, and one was excluded as a result of the Delphi. Thirteen outcomes were brought to the hybrid consensus meeting as a result of Delphi and two outcomes, 'allergic symptoms' and 'quality of life' achieved consensus for inclusion as 'core' outcomes.
Conclusion: In addition to the mandatory reporting of adverse events for FA clinical trials or observational studies of interventions, allergic symptoms and quality of life should be measured as core outcomes. Future work by COMFA will define how best to measure these core outcomes.
Keywords: allergic symptoms; core outcome set; food allergy; outcome assessment; quality of life.
© 2024 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
References
REFERENCES
-
- Warren C, Dyer A, Lombard L, Dunn‐Galvin A, Gupta R. The psychosocial burden of food allergy among adults: A US population‐based study. J Allergy Clin Immunol Pract. 2021;9(6):2452‐2460.e3.
-
- Sindher SB, Long A, Chin AR, et al. Food allergy, mechanisms, diagnosis and treatment: Innovation through a multi‐targeted approach. Allergy. 2022;77(10):2937‐2948.
-
- Kirkham JJ, Gorst S, Altman DG, et al. Core outcome set‐STAndards for reporting: The COS‐STAR statement. PLoS Med. 2016;13(10):e1002148.
-
- Leshem YA, Simpson EL, Apfelbacher C, et al. The Harmonising outcome measures for eczema (HOME) implementation roadmap. Br J Dermatol. 2023;189:710‐718.
-
- Smith TO, Hawker GA, Hunter DJ, et al. The OMERACT‐OARSI Core domain set for measurement in clinical trials of hip and/or knee osteoarthritis. J Rheumatol. 2019;46(8):981‐989.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous